our team

Gordana Gregurić Čičak, MD Chief Executive Officer

Gordana joined the CRO industry in 1998 in the role of Medical Research Associate and since then has gained almost 20 years of working experience in the international clinical research arena.

Gordana performed various Clinical Project Management and Senior Management positions within leading Global (Ingenix, i3 research) and Regional/International CRO companies (SAR Monitoring Services, Ergomed), including the Regional and Country business responsibilities.

She was a Board Member of the Ingenix Pharmaceutical Services (i3 research) in Croatia. Since 2006, Co-founder and CEO of OPTIMAPHARM.

Gordana graduated from the Medical School, University of Zagreb in 1995. In 2001, she completed postgraduate studies in Clinical Pharmacology with Toxicology.

Christophe Lyssens, MSc Vice President Clinical Operations

Christophe holds a Master of Science in Biology from the University of Antwerp (Belgium). After working on University Research projects, Christophe started his career in the pharma industry in 2003.

He worked in different positions of increasing responsibility at a CRO, global Pharma and Biotech company.

Christophe then joined a Global CRO in 2011 as senior Clinical Vendor Manager EMEA and was responsible for the selection, contracting, quality and performance of partner CROs in the EMEA region.

In 2014 he received additional responsibility as the Country Head for Greece.

Nikola Strumberger, MD Vice President Business Development

Nikola is Medical Doctor by background and has spent 12 years in Clinical Research, working both from sponsors and CRO perspective.

Nikola started as CRA in Novo Nordisk, swiftly moving towards position of Regional Manager running trials in most active European regions.

In 2010, Nikola has joined Optimapharm as Country Manager Serbia, one of the Adriatic region countries that has under his management grown over 500%.

After working as Clinical Operations Director, Nikola has moved towards Business Development, becoming among rare BD persons with such previous experience in Clinical Operations.

Nikola is engaged in active promotion of emerging markets as future of clinical trials.

Mirna Šenjug, MA in Economics, CFA Chief Financial Officer

Mirna is a finance expert with extensive experience in investment banking, controlling, and finance management. Her career started in the investment banking division of Intessa Sanpaolo PBZ.

Mirna has worked on many industry and company analyses, company valuations, business planning and M&A transactions gaining valuable experience in financial modeling, strategic planning and market research.

Later, she was responsible for setting up the controlling department in a regional commercial bank, working closely with the Management and Supervisory Board on strategic planning, ALM, external audits and investor relations. In 2012 Mirna joined OPTIMAPHARM's team as Chief Financial Officer.

Igor Čičak, MA in Economics President of Supervisory Board

During period 2006-2011, Igor served as CEO of VABA d.d. Bank Varaždin, a commercial regional bank based in Croatia.

From 2005 - 2006, Igor performed position of Vice president and Board Member of Agrokor d.d., large food and retail company from Croatia. Igor was responsible for corporate finance and international markets.

Prior to that, Igor was the Head of corporate banking division at HVB/Unicredit Group in Croatia.

Igor is founding shareholder of OPTIMAPHARM and serves as President of the Supervisory Board since 2011.

Igor is also Managing Partner and founder of Provectus Capital, an M&A and investment banking firm active in SEE region.

Education: London Business School - Senior Executive Programme (2014);
General Management Program Wirtschaftsuniversität Wien, Austria (2004);
1990 – 1995: Faculty of Economic Science, University of Zagreb, B. Sci. Economics.